143 A novel liquid nitrogen-free snap freezer REFERENCES 1. Mateo, J., et al. Delivering precision oncology to patients with cancer. Nat Med 28, 658-665 (2022). 2. Rodriguez, H., Zenklusen, J.C., Staudt, L.M., Doroshow, J.H. & Lowy, D.R. The next horizon in precision oncology: Proteogenomics to inform cancer diagnosis and treatment. Cell 184, 1661-1670 (2021). 3. Malone, E.R., Oliva, M., Sabatini, P.J.B., Stockley, T.L. & Siu, L.L. Molecular profiling for precision cancer therapies. Genome Med 12, 8 (2020). 4. Barnes, R.O., Parisien, M., Murphy, L.C. & Watson, P.H. Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 17, 3344-3350 (2008). 5. Tang, W., Hu, Z., Muallem, H. & Gulley, M.L. Quality assurance of RNA expression profiling in clinical laboratories. J Mol Diagn 14, 1-11 (2012). 6. Mazur, P. Stopping biological time. The freezing of living cells. Ann N Y Acad Sci 541, 514-531 (1988). 7. Baust, J.G., Gao, D. & Baust, J.M. Cryopreservation: An emerging paradigm change. Organogenesis 5, 90-96 (2009). 8. Srinivas Vanapalli, S.J., Harry Holland, Marcel ter Brake. A tissue snap-freezing apparatus without sacrificial cryogens. IOP Conf. Ser.: Mater. Sci. Eng. 278(2017). 9. Mazur, P. Cryobiology: the freezing of biological systems. Science 168, 939-949 (1970). 10. Hunt, C.J. Cryopreservation: Vitrification and Controlled Rate Cooling. Methods Mol Biol 1590, 41-77 (2017). 11. Steu, S., et al. A procedure for tissue freezing and processing applicable to both intra-operative frozen section diagnosis and tissue banking in surgical pathology. Virchows Arch 452, 305-312 (2008). 12. Engel, K.B., Vaught, J. & Moore, H.M. National Cancer Institute Biospecimen Evidence-Based Practices: A Novel Approach to Pre-analytical Standardization. Biopreservation and Biobanking 12, 148-150 (2014). 13. van Limbeek, M.A.J., Jagga, S., Holland, H., Ledeboer, K., Ter Brake, M. & Vanapalli, S. Cooling of a vial in a snapfreezing device without using sacrificial cryogens. Sci Rep 9, 3510 (2019). 14. Labots, M., et al. Kinase Inhibitor Treatment of Patients with Advanced Cancer Results in High Tumor Drug Concentrations and in Specific Alterations of the Tumor Phosphoproteome. Cancers (Basel) 12(2020). 15. Labots, M., et al. Phosphotyrosine-based-phosphoproteomics scaled-down to biopsy level for analysis of individual tumor biology and treatment selection. J Proteomics 162, 99-107 (2017). 16. Jewell, S.D., et al. Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. Am J Clin Pathol 118, 733-741 (2002). 5
RkJQdWJsaXNoZXIy MTk4NDMw